Inactive Instrument

All News Synthorx, Inc.

Equities

US87167A1034

All News

Unlock all the news on all businesses: Never miss an investment opportunity again!

Synthorx, Inc.(NasdaqGS:THOR) dropped from S&P Global BMI Index	20-01-24	CI
Synthorx, Inc.(NasdaqGM:THOR) dropped from S&P TMI Index	20-01-24	CI
SYNTHORX, INC. : Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control or Registrant, Change in Directors or Principal Officers, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits (form 8-K)	20-01-23	AQ
Synthorx, Inc. Announces Executive Changes	20-01-23	CI
Synthorx, Inc.(NasdaqGS:THOR) dropped from NASDAQ Composite Index	20-01-23	CI
Sanofi completed the acquisition of Synthorx, Inc. from Avalon Ventures, LLC, Correlation Ventures, OrbiMed Advisors LLC, Medicxi Ventures (UK) LLP and others.	20-01-22	CI
Sanofi : - Hart-Scott-Rodino waiting period expires for Sanofi :'s acquisition of Synthorx	20-01-21	AQ
Tesla gets Chinese boost, Boeing’s new troubles, scandal for Tesco…	19-12-23
WeissLaw LLP Investigates Synthorx, Inc.	19-12-12	PR
Sanofi : to acquire Synthorx to bolster its immuno-oncology pipeline for $2.5 Billion	19-12-10	AQ
Synthorx : Sanofi shares rally on new margin goals, narrower drug focus	19-12-10	RE
Synthorx : Sanofi ends research in diabetes, narrows units to spur profit	19-12-09	RE
Synthorx : Drug giant Sanofi to buy U.S. biotech firm Synthorx for $2.5B	19-12-09	AQ
European shares dragged down by Tullow Oil and weak China export data	19-12-09	RE
SYNTHORX, INC. : Entry into a Material Definitive Agreement, Change in Directors or Principal Officers, Other Events, Financial Statements and Exhibits (form 8-K)	19-12-09	AQ
Synthorx : France's Sanofi to buy biotech firm Synthorx for $2.5 billion	19-12-09	RE
Synthorx : France's Sanofi to buy biotech firm Synthorx for $2.5 billion	19-12-09	RE
Sanofi entered into definitive agreement to acquire Synthorx, Inc. from Avalon Ventures, LLC, Correlation Ventures, OrbiMed Advisors LLC, Medicxi Ventures (UK) LLP and others for $2.2 billion.	19-12-08	CI
Synthorx to Present at Upcoming Investor Conferences	19-11-13	GL
Synthorx, Inc. Reports Earnings Results for the Third Quarter Ended September 30, 2019	19-11-05	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

All News Synthorx, Inc.

Equities

US87167A1034

All News

Filters